MORGAN STANLEY - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$77,183,771
+19.2%
485,400
+6.1%
0.01%
+33.3%
Q2 2023$64,739,862
+5.0%
457,653
+25.0%
0.01%
-14.3%
Q1 2023$61,644,680
-12.3%
366,147
-11.8%
0.01%
-12.5%
Q4 2022$70,317,490
+42.6%
415,318
+57.6%
0.01%
+14.3%
Q3 2022$49,318,000
+35.4%
263,564
+17.5%
0.01%
+40.0%
Q2 2022$36,419,000
+35.1%
224,257
+56.4%
0.01%
+25.0%
Q1 2022$26,967,000
-19.0%
143,368
+14.1%
0.00%0.0%
Q4 2021$33,279,000
+29.2%
125,657
+41.0%
0.00%
+33.3%
Q3 2021$25,762,000
+5.0%
89,146
-27.5%
0.00%0.0%
Q2 2021$24,529,000
+8.9%
122,884
+6.1%
0.00%0.0%
Q1 2021$22,516,000
+7.2%
115,821
+5.6%
0.00%0.0%
Q4 2020$21,011,000
+145.6%
109,651
+89.1%
0.00%
+50.0%
Q3 2020$8,556,000
+73.7%
57,988
+45.5%
0.00%
+100.0%
Q2 2020$4,926,000
+52.2%
39,858
+18.9%
0.00%0.0%
Q1 2020$3,236,000
-71.3%
33,518
-72.5%
0.00%
-66.7%
Q4 2019$11,256,000
-41.3%
121,688
-51.4%
0.00%
-40.0%
Q3 2019$19,190,000
+8.5%
250,215
+21.6%
0.01%0.0%
Q2 2019$17,688,000
+99.6%
205,796
+37.2%
0.01%
+66.7%
Q1 2019$8,862,000
-51.5%
149,982
-56.7%
0.00%
-40.0%
Q4 2018$18,276,000
+29.9%
346,522
+36.6%
0.01%
+25.0%
Q3 2018$14,072,000
+75.5%
253,733
+48.8%
0.00%
+100.0%
Q2 2018$8,020,000
+142.8%
170,507
+86.8%
0.00%
+100.0%
Q1 2018$3,303,000
-17.3%
91,271
-17.1%
0.00%0.0%
Q4 2017$3,993,000
+46.9%
110,076
+55.1%
0.00%0.0%
Q3 2017$2,719,000
+42.4%
70,955
+53.9%
0.00%0.0%
Q2 2017$1,910,000
-58.8%
46,098
-65.0%
0.00%0.0%
Q1 2017$4,640,000
-28.5%
131,798
-37.4%
0.00%0.0%
Q4 2016$6,494,000
+801.9%
210,640
+782.9%
0.00%
Q3 2016$720,000
-76.9%
23,859
-79.1%
0.00%
-100.0%
Q2 2016$3,119,000
-44.4%
113,966
-45.6%
0.00%
-50.0%
Q1 2016$5,613,000
+62.8%
209,309
+71.7%
0.00%
+100.0%
Q4 2015$3,448,000
-23.6%
121,884
-24.8%
0.00%
-50.0%
Q3 2015$4,513,000
+83.5%
162,074
+172.0%
0.00%
+100.0%
Q2 2015$2,459,000
+250.8%
59,589
+158.2%
0.00%
Q1 2015$701,000
+102.0%
23,078
+31.7%
0.00%
Q4 2014$347,000
-79.1%
17,524
-79.0%
0.00%
-100.0%
Q3 2014$1,663,000
-33.2%
83,542
-23.5%
0.00%0.0%
Q2 2014$2,490,000
+113.9%
109,241
+20.6%
0.00%
Q1 2014$1,164,000
-6.0%
90,575
-0.2%
0.00%
-100.0%
Q4 2013$1,238,000
+85.1%
90,754
+50.5%
0.00%
Q3 2013$669,000
-24.2%
60,315
-43.7%
0.00%
Q2 2013$883,000107,1840.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders